|
DE3834132A1
(de)
|
1988-10-07 |
1990-04-12 |
Knoll Ag |
Hydroxypropafenonglyceride
|
|
GB9221220D0
(en)
|
1992-10-09 |
1992-11-25 |
Sandoz Ag |
Organic componds
|
|
MY115461A
(en)
|
1995-03-30 |
2003-06-30 |
Wellcome Found |
Synergistic combinations of zidovudine, 1592u89 and 3tc
|
|
ATE286884T1
(de)
|
1996-03-28 |
2005-01-15 |
Shionogi & Co |
Durch lymphe absorbierbare imidazolderivate
|
|
US5962440A
(en)
|
1996-05-09 |
1999-10-05 |
Bristol-Myers Squibb Company |
Cyclic phosphonate ester inhibitors of microsomal triglyceride transfer protein and method
|
|
US6200530B1
(en)
*
|
2000-03-09 |
2001-03-13 |
Michael Markels, Jr. |
Method of sequestering carbon dioxide with spiral fertilization
|
|
US6013665A
(en)
|
1997-12-16 |
2000-01-11 |
Abbott Laboratories |
Method for enhancing the absorption and transport of lipid soluble compounds using structured glycerides
|
|
US7635690B2
(en)
|
1999-01-22 |
2009-12-22 |
Emory University |
HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine
|
|
DE60037345T2
(de)
|
1999-12-10 |
2008-11-13 |
Pfizer Products Inc., Groton |
Pyrrolo(2,3-d)pyrimidin-Verbindungen
|
|
PE20020354A1
(es)
|
2000-09-01 |
2002-06-12 |
Novartis Ag |
Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
|
|
JP4324343B2
(ja)
|
2001-04-24 |
2009-09-02 |
富士フイルム株式会社 |
トリヨードフェニル基及びステロイド残基を有する化合物
|
|
DE60217322T2
(de)
|
2001-04-27 |
2007-10-04 |
Zenyaku Kogyo K.K. |
Heterocyclische verbindung und antitumormittel, das diese als wirkstoff enthält
|
|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
|
PT1536827E
(pt)
|
2002-08-14 |
2009-03-20 |
Silence Therapeutics Ag |
Utilização de proteína cinase n beta
|
|
AU2004228668B2
(en)
|
2003-04-03 |
2011-10-27 |
Park Funding, Llc |
PI-3 kinase inhibitor prodrugs
|
|
ES2382377T3
(es)
|
2003-05-30 |
2012-06-07 |
Gemin X Pharmaceuticals Canada Inc. |
Compuestos triheterocíclicos, composiciones, y métodos para tratar cáncer
|
|
EP1692153A4
(en)
|
2003-07-03 |
2007-03-21 |
Univ Pennsylvania |
INHIBITION OF EXPRESSION OF SYK-KINASE
|
|
CN1867664A
(zh)
|
2003-10-17 |
2006-11-22 |
兰贝克赛实验室有限公司 |
使用新的链霉菌菌种生产他克莫司(fk－506)
|
|
WO2005113556A1
(en)
|
2004-05-13 |
2005-12-01 |
Icos Corporation |
Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
|
|
JP4806680B2
(ja)
|
2004-05-19 |
2011-11-02 |
メダレックス インコーポレイテッド |
自己犠牲リンカー及び薬剤複合体
|
|
AU2006206458B2
(en)
|
2005-01-19 |
2012-10-25 |
Rigel Pharmaceuticals, Inc. |
Prodrugs of 2,4-pyrimidinediamine compounds and their uses
|
|
PL1888550T3
(pl)
|
2005-05-12 |
2014-12-31 |
Abbvie Bahamas Ltd |
Promotory apoptozy
|
|
GB0510390D0
(en)
|
2005-05-20 |
2005-06-29 |
Novartis Ag |
Organic compounds
|
|
US7402325B2
(en)
|
2005-07-28 |
2008-07-22 |
Phoenix Biotechnology, Inc. |
Supercritical carbon dioxide extract of pharmacologically active components from Nerium oleander
|
|
US7989622B2
(en)
|
2005-10-07 |
2011-08-02 |
Exelixis, Inc. |
Phosphatidylinositol 3-kinase inhibitors and methods of their use
|
|
JP5191391B2
(ja)
|
2005-11-01 |
2013-05-08 |
ターゲジェン インコーポレーティッド |
キナーゼのビ−アリールメタ−ピリミジン阻害剤
|
|
SG10202003901UA
(en)
|
2005-12-13 |
2020-05-28 |
Incyte Holdings Corp |
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
|
|
JO2660B1
(en)
|
2006-01-20 |
2012-06-17 |
نوفارتيس ايه جي |
Pi-3 inhibitors and methods of use
|
|
US20090023805A1
(en)
|
2006-02-13 |
2009-01-22 |
Anne Claire Marrast |
Method of administration
|
|
WO2007129161A2
(en)
|
2006-04-26 |
2007-11-15 |
F. Hoffmann-La Roche Ag |
Thieno [3, 2-d] pyrimidine derivative useful as pi3k inhibitor
|
|
DK2526933T3
(en)
|
2006-09-22 |
2015-05-18 |
Pharmacyclics Inc |
Inhibitors of Bruton's tyrosine kinase
|
|
TW200824713A
(en)
|
2006-10-18 |
2008-06-16 |
Wyeth Corp |
Processes for the synthesis of individual isomers of mono-PEG CCI-779
|
|
KR101566840B1
(ko)
|
2007-03-12 |
2015-11-06 |
와이엠 바이오사이언시즈 오스트레일리아 피티와이 엘티디 |
페닐 아미노 피리미딘 화합물 및 이의 용도
|
|
WO2008118802A1
(en)
|
2007-03-23 |
2008-10-02 |
Regents Of The University Of Minnesota |
Therapeutic compounds
|
|
CN101730706B
(zh)
|
2007-05-11 |
2015-04-15 |
生物科技研究有限公司 |
具有神经保护和增强记忆活性的受体拮抗剂
|
|
PE20090717A1
(es)
|
2007-05-18 |
2009-07-18 |
Smithkline Beecham Corp |
Derivados de quinolina como inhibidores de la pi3 quinasa
|
|
KR100975520B1
(ko)
|
2008-02-01 |
2010-08-12 |
종근당바이오 주식회사 |
마이코페놀레이트 모페틸의 개선된 제조방법
|
|
EP2260052A4
(en)
*
|
2008-02-26 |
2013-01-16 |
Univ Emory |
STEROIDANALOGA FOR NEUROPROTEKTION
|
|
HUE029767T2
(en)
|
2008-03-11 |
2017-04-28 |
Incyte Holdings Corp |
JAK inhibitor azetidine and cyclobutane derivatives
|
|
JP5757864B2
(ja)
|
2008-05-20 |
2015-08-05 |
ニューロジェシックス， インコーポレイテッド |
水溶性アセトアミノフェン類似体
|
|
US8648119B2
(en)
|
2008-05-23 |
2014-02-11 |
Otonomy, Inc. |
Controlled release immunomodulator compositions and methods for the treatment of otic disorders
|
|
US8338439B2
(en)
|
2008-06-27 |
2012-12-25 |
Celgene Avilomics Research, Inc. |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
|
CN101676291B
(zh)
|
2008-09-18 |
2012-05-09 |
上海海和药物研究开发有限公司 |
一类雷帕霉素碳酸酯类似物、其药物组合物及其制备方法和用途
|
|
US8535655B2
(en)
*
|
2008-10-10 |
2013-09-17 |
Polyactiva Pty Ltd. |
Biodegradable polymer—bioactive moiety conjugates
|
|
WO2011051967A2
(en)
|
2009-10-23 |
2011-05-05 |
Alkem Laboratories Ltd |
Pharmaceutical compositions comprising mycophenolate and processes for preparing thereof
|
|
US20110213028A1
(en)
|
2010-02-26 |
2011-09-01 |
Catabasis Pharmaceuticals, Inc. |
Fatty acid mycophenolate derivatives and their uses
|
|
US20130245253A1
(en)
|
2010-03-26 |
2013-09-19 |
Department Of Veterans Affairs |
Conjugated Neuroactive Steroid Compositions And Methods Of Use
|
|
WO2012131019A1
(en)
|
2011-04-01 |
2012-10-04 |
Sandoz Ag |
Regioselective acylation of rapamycin at the c-42 position
|
|
ES3018133T3
(en)
|
2011-11-30 |
2025-05-14 |
Univ Emory |
Jak inhibitors for use in the prevention or treatment of a viral disease caused by a coronaviridae
|
|
GB201304662D0
(en)
|
2013-03-14 |
2013-05-01 |
Sigmoid Pharma Ltd |
Compositions
|
|
AU2015210833B2
(en)
|
2014-02-03 |
2019-01-03 |
Vitae Pharmaceuticals, Llc |
Dihydropyrrolopyridine inhibitors of ROR-gamma
|
|
CN117088931A
(zh)
*
|
2014-08-12 |
2023-11-21 |
莫纳什大学 |
定向淋巴的前药
|
|
US11738087B2
(en)
*
|
2015-09-08 |
2023-08-29 |
Monash University |
Lymph directing prodrugs
|
|
AU2016354564B2
(en)
|
2015-11-12 |
2021-04-29 |
Board Of Regents Of The University Of Nebraska |
Polyethylene glycol-conjugated glucocorticoid prodrugs and compositions and methods thereof
|
|
CN110418796A
(zh)
|
2017-03-08 |
2019-11-05 |
施万生物制药研发Ip有限责任公司 |
托法替尼(tofacitinib)的葡萄糖苷酸前药
|
|
CA3068462A1
(en)
|
2017-06-23 |
2019-12-27 |
The Board Of Trustees Of The University Of Illinois |
Treatment of neuropsychiatric disorders with neurosteroids and analogues thereof
|
|
US20190065544A1
(en)
|
2017-08-29 |
2019-02-28 |
Walmart Apollo, Llc |
System and method for collaborative sharing of database information
|
|
CA3077739A1
(en)
|
2017-08-29 |
2019-03-07 |
Puretech Lyt, Inc. |
Lymphatic system-directing lipid prodrugs
|
|
AR116659A1
(es)
*
|
2018-05-04 |
2021-06-02 |
Acerus Pharmaceuticals Corp |
Derivados de neuroesteroides y usos de estos
|
|
CA3107481A1
(en)
|
2018-08-02 |
2020-02-06 |
Puretech Lyt, Inc. |
Lipid prodrugs of pregnane neurosteroids and uses thereof
|
|
WO2020176856A1
(en)
|
2019-02-28 |
2020-09-03 |
Puretech Lyt, Inc. |
Lipid prodrugs of glucocorticoids and uses thereof
|
|
IL295362A
(en)
|
2020-02-05 |
2022-10-01 |
Puretech Lyt Inc |
Lipid drug inhibitors of neurosteroids
|